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Abstract
Objective—We examined the acceptability of the influenza A (H1N1) and seasonal vaccinations
immediately following government manufacture approval to gauge potential product uptake in
minority communities. We studied correlates of vaccine acceptance including attitudes, beliefs,
perceptions, and influenza immunization experiences, and sought to identify communication
approaches to increase influenza vaccine coverage in community settings.
Methods—Adults ≥ 18 years participated in a cross-sectional survey from September through
December 2009. Venue-based sampling was used to recruit participants of racial and ethnic
minorities.
Results—The sample (N=503) included mostly lower income (81.9%, n=412) participants and
African Americans (79.3%, n=399). Respondents expressed greater acceptability of the H1N1
vaccination compared to seasonal flu immunization (t=2.86, p=0.005) although H1N1 vaccine
acceptability was moderately low (38%, n=191). Factors associated with acceptance of the H1N1
vaccine included positive attitudes about immunizations [OR=0.23, CI (0.16, 0.33)], community
perceptions of H1N1 [OR=2.15, CI (1.57, 2.95)], and having had a flu shot in the past 5 years
[OR=2.50, CI (1.52, 4.10). The factors associated with acceptance of the seasonal flu vaccine
included positive attitudes about immunization [OR=0.43, CI (0.32, 0.59)], community
perceptions of H1N1 [OR=1.53, CI (1.16, 2.01)], and having had the flu shot in the past 5 years
[OR=3.53, CI (2.16, 5.78)]. Participants were most likely to be influenced to take a flu shot by
physicians [OR=1.94, CI (1.31, 2.86)]. Persons who obtained influenza vaccinations indicated that
Facebook (χ2=11.7, p=.02) and Twitter (χ2=18.1, p=.001) could be useful vaccine
communication channels and that churches (χ2=21.5, p<.001) and grocery stores (χ2=21.5, p<.
001) would be effective “flu shot stops” in their communities.
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Conclusions—In this population, positive vaccine attitudes and community perceptions, along
with previous flu vaccination, were associated with H1N1 and seasonal influenza vaccine
acceptance. Increased immunization coverage in this community may be achieved through
physician communication to dispel vaccine conspiracy beliefs and discussion about vaccine
protection via social media and in other community venues.
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Introduction
In early April 2009, reports emerged from Mexico about a novel viral pathogen that had
genetic similarity with Asian, European, and North American swine influenza A virus.[1]
Shortly thereafter, the virus that became known as “2009 H1N1” also was detected in two
children living approximately 130 miles from each other in California.[2-4] On June 11,
2009, the World Health Organization (WHO) declared the worldwide outbreak of 2009
influenza A (H1N1) a pandemic [5]. Following the WHO’s pandemic declaration,
worldwide mobilization to develop a vaccine was expeditious [6]. The CDC Advisory
Committee on Immunization Practices (ACIP) provided guidance in July 2009 on initial
priority groups for vaccination including pregnant women, household contacts and
caregivers of infants ≤ 6 months of age, persons in 6 months-24 years, adults ages 25-64
years of age at risk from influenza medical complications, and healthcare workers and
emergency personnel.
Although the WHO subsequently declared the end of the pandemic in August 2010 [7], the
virus took its toll in terms of morbidity and mortality during this short time. From April
2009 to April 2010, it is estimated that there were nearly 60.8 million cases of H1N1 in the
United States, resulting in 274,304 hospitalizations and 12,469 deaths [8]. H1N1 affected
healthy persons under age 65 [9]. Hospitalization and H1N1-associated deaths were most
likely to occur in people with at least one underlying medical condition [10, 11]. Although
H1N1 infection rates appeared to be similar among Hispanics, non-Hispanic whites, and
non-Hispanic blacks [10], minority populations have been burdened by some of the
underlying medical conditions which most commonly led to H1N1-related complications,
such as asthma, diabetes, and immunosuppressive conditions [12-15].
Despite challenges to vaccine development and licensure in the United States, a safe and
effective H1N1 vaccine was approved by the US Food and Drug Administration (FDA) and
available to the public by October 2009 [6, 16]. Given that vaccination is one of the most
effective methods to reduce the spread and impact of influenza [17], high rates of H1N1
vaccine uptake would likely have reduced disease burden. However, H1N1 vaccination
coverage among adults in the United States remained low. From November 2009 – February
2010, the CDC estimated 20.1% coverage among adults aged ≥18 years, with wide
variations by state [18].
In light of recent research indicating the risk of future influenza pandemics still exists [19],
it is important to investigate the reasons why the national H1N1 vaccination effort fell short
of targeted levels. Previous studies have highlighted important factors that influenced H1N1
immunization uptake[20, 21] including those with general populations from Australia[22],
France[23], Greece[24] , Hong Kong [25], Israel [26], Malaysia[27], UK[28], US[28, 29],
South Korea[30], and Turkey[31] Across contexts issues such as perceived risk and disease
vulnerability, attitudes toward influenza vaccination, and immunization history strongly
correlated with willingness to obtain A/H1N1 vaccination during the pandemic.[21].[20]
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Yet, globally immunization rates were much lower than anticipated.[32] Domestically, there
were considerable disparities observed across racial and ethnic groups with respect to H1N1
exposure, healthcare access, and illness complications, as well as vaccine uptake.[33, 34]
Therefore, it is particularly crucial to elucidate factors associated with vaccine acceptance
among high-risk populations, including low-income and minority populations who may be
at greater risk for disease complications due to a disproportionate burden of underlying
medical conditions. However, there is little data on factors influencing H1N1 acceptance in
minority populations.
The present study was conducted to assess factors associated with both H1N1 and seasonal
influenza vaccine acceptance among a predominantly low-income, high-minority sample of
adults in Atlanta, Georgia. Established health behavior theories, specifically the Health
Belief Model [35], and the Integrated Behavioral Model which incorporates socioecological
influences [36-38] were used as a framework to examine factors associated with H1N1 and
seasonal influenza vaccine acceptance.
Patients and Methods
Study design and sample
From September through December 2009, a venue-based sampling strategy was utilized for
recruitment during randomly selected blocks of time. Venue-based sampling involves
identifying days and times when the target population frequents specific venues,
constructing a sampling frame of venue day-time units (VDTs), and randomly selecting
recruitment blocks from said sampling frame. This method has proven successful in
obtaining representative populations in cross-sectional survey samples [39]. Study settings
were located throughout metropolitan Atlanta, Georgia. The sampling locations included 33
locations including churches, bookstores, educational forums, community meetings, and
special events such as family health fairs that demonstrated the potential to recruit an
adequate number of participants.
Our target populations included English- and Spanish-speaking racial and ethnic minority
(predominately African American and Hispanic) persons ages ≥18 years. We calculated an
estimated needed sample size of n=460 to see an effect size of 0.03 with 6 potential
predictors in the model at 80% power (alpha=.05).[40] Project assistants performed
recruitment and data collection based on a master schedule of monthly activities. Persons
were eligible for this study if they were ≥18 years of age and could read and speak English
or Spanish. Native Spanish-speaking staff members were available during the survey
administration and Spanish surveys were given to those whose first language is Spanish.
Seven hundred thirty-six people were invited to participate and 604 provided written
informed consent and subsequently completed self-administered paper questionnaires
(response rate = 82%). A $10 gift card or health promotion incentive was offered for
participation. The Emory University Institutional Review Board approved the study.
Measurement
Assessment of Acceptability—The acceptability of the H1N1 vaccine was assessed by
a single item: “On a scale of 0 (definitely not) to 10 (definitely so), please rank your
likelihood getting a swine (H1N1) flu vaccine in the next year?” Similarly, seasonal
influenza immunization acceptability was measured by the item: “On a scale of 0 (definitely
not) to 10 (definitely so), please rank your likelihood of getting yearly (seasonal) flu shot in
the next 90 days (not swine flu)?” We subsequently split responses into two categories
indicating those “willing” and “not willing” to take H1N1 or seasonal influenza vaccine in
the next six months.
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Assessment of demographic and behavioral correlates—Initial questions assessed
basic demographic measures (e.g., age, gender, race/ethnicity, education, employment
status). Age was split into three groups that represent the targeted groups for both vaccines
(i.e., ages 18-24, 25-63, and 64-70). Additional items assessed recent healthcare
experiences. For example, using a 12-month recall period, we asked about recent treatment
for illness or health condition by a healthcare provider (0 to ≥ 10 times in the past year).
Questions also assessed indicators of influenza vaccination history and recent seasonal and
H1N1 influenza-related illness experiences. Finally, we examined participants’ willingness-
to-pay for H1N1 vaccinations (i.e., $0/free to ≥$30) using a 5-point scale.
Assessment of psychosocial correlates—In addition to the selected demographic
and behavioral correlates, the questionnaire included items designed to measure
psychosocial indicators of H1N1 and seasonal vaccine immunization acceptability. New
scale items were developed based on previous quantitative and qualitative research findings,
literature review, and vaccine clinical trial and community experience. [41-44] In addition,
psychosocial items were developed for most of the domains based on recommendations by
behavioral theorists, guided by the Health Belief and Integrated Behavioral Models [36-38,
45, 46]. A team of clinicians and behavioral researchers reviewed the instrument for
adequacy of the measures.
The following briefly describes six scale measures developed specifically to assess
immunization issues. Each scale item was measured by a 5-point Likert scale (1-strongly
disagree to 5-strongly agree), designed to assign meaningful values to an underlying
continuum of ratings [47]. These scales were added to the multivariate models as scores
based on the average of the component answers of the scale.
Immunization Attitudes: Ten items comprised this scale. Three items assessed the benefit
of taking the vaccine to set an example and encourage others to get vaccinated, and four
items measured the perceived benefit of the novel H1N1 vaccine for self, family, and
community. The remaining three items assessed other positive attitudes toward vaccination
including the vaccine does not seem risky, would be worth the time and trouble, and would
be worth the extra immunization cost compared to seasonal flu shot expense One item
assessed perceived threat of swine flu based on lifetime experience.
Vaccine Attributes: We evaluated the extent to which people considered clinical trial
testing, minor side effects, long-term safety, out-of-pocket cost, and immunization
recommendation from others who already obtained the H1N1 vaccine in decision-making
via 5 items in this scale.
Disease Salience: This scale comprised five items. Five items assessed community
perceptions regarding H1N1 compared to other health concerns, such as HIV/AIDS,
substance abuse, breast cancer, and depression. One item assessed the extent of agreement
with the statement, “Most people in my community do not care about swine (H1N1) flu.”
Community Perceptions of H1N1: This scale measures disease conspiracy beliefs and the
extent of mistrust of H1N1 information coming from the government that serve as a
potential barrier to vaccination.[32] Two items state “The US government created swine
(H1N1) flu” and “Swine (H1N1) flu is a government conspiracy.” The scale also includes an
item that measures the extent of agreement to the statement, “Swine (H1N1) flu is just like
other epidemics affecting my community.”
Health Status: Previous studies that have examined H1N1 vaccination attitudes highlight
the relationship of perceived health threat, disease susceptibility, and immunization
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behavior.[21, 33] As racial and ethnic minorities share a disproportionate burden of
underlying medical conditions that may place them at greater risk for H1N1-related
complications [33, 48, 49], we assessed extent of agreement with the statement “I am as
healthy as I can be.” We also examined if there was any perceived variance in health status
in the next year with the item, “My health will not decline in the next year.”
Normative Approval: Previous studies examining vaccine acceptability have accounted for
normative expectations in overall models [50, 51]. Given the extent of evidence suggesting
the importance of normative approval as a vaccine decision-making facilitator [42, 44, 52],
we developed four items that specifically assessed the expressed or perceived approval of
doctors, family, work colleagues, and friends in deciding to get the H1N1 vaccination within
six months.
Communication Assessment
Ten items salient to improving H1N1 vaccination through communication channels and
venues were assessed. These included three items regarding about influential sources of
vaccine information in the community including physicians/healthcare providers, friends,
and media. In addition, five items inquired about desired locations to obtain influenza shots
(grocery stores, churches, schools, employers, and health departments). Finally, two items
assessing the relevance of social networking sites (Twitter, Facebook) in promoting
vaccination.
Statistical Analysis—SAS version 9.2 was used for analyses (SAS Institute Inc, Cary,
NC, USA). Descriptive statistics and cross-tabulations were generated for variables of
interest. Bivariate correlations were also generated to explore key relationships. An
exploratory factor analysis was conducted and resulting scale reliability estimates were
generated. We determined a Cronbach alpha reliability estimate of ≥ 0.70 would support
reliability of each subscale [53]. Multivariate logistic regression models were used to
analyze the independent contributions of variables. Significant independent predictors of
outcomes were assessed at α=0.05 levels.
Results
Subjects
Fifty-one percent of the study population were female (n=256), 43.1% were male (217),
(6.0%, n=30 did not record gender) (Table 1). The mean age of the participants was 37.4
years old, with a majority of participants in the age category 25-63 [22.1% age 18-24
(n=111); 70.4% age 25-63 (n=354); 2.4% age 64-70 (n=12)]. All of the 503 participants
surveyed were non-white minorities including 399 black/African Americans (79.3%), 31
Hispanics/Latino/as (6.2%), 28 persons of multiracial descent (5.6%), 12 Asians (2.4%), and
6 Native American Indians (1.2%). Five percent (n=27) of respondents did not identify their
ethnicity. Respondents predominately lived in lower-income households with earnings of ≤
$40,000 per year (81.9%, n=412). Forty-nine percent (n=245) were unemployed and 42.5%
(n=214) had achieved a high school or equivalent education with an additional 16.7%
(n=84) achieving less than a high school education. Many participants received some form
of public assistance (45.3%, n=228), with food stamps being the most utilized (36.6%,
n=184). Most participants also reported renting a home (54.5%, n=274) and living in their
current residence for three years or less (74.6%, n=375).
Most respondents (90.5%, n=455) were English-speaking with 5.2% (n=26) having Spanish
as their primary household language. A small minority (2.8%, n=14) reported another
primary household language. Similarly, most respondents (83.1%, n=418) were born in the
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United States, with another 3.0% of respondents born in Mexico (n=15), and 7.2% born in
other countries (n=36). Seven percent (n=34) of participants did not report their country of
birth.
Internal Consistencies
With 29 questionnaire items, we conducted an exploratory principal components factor
analysis using Varimax rotation method that resulted in a 6-factor solution (63% cumulative
variance). The internal consistencies achieved on the six scales demonstrated a high level of
reliability. “Immunization Attitudes” resulted in the highest alpha score of 0.92. This was
followed by “Normative Approval” (α = 0.90), “Community Perceptions of H1N1” (α =
0.77), Vaccine Attributes” (α = 0.76), “Disease Salience” (α = .74), and the “Health Status”
scale (α = 0.71).
Vaccine Acceptability
Respondents reported a greater likelihood of getting the H1N1 flu vaccine (χ2=3.63)
compared to the seasonal flu vaccine (χ2=3.20) (t=-2.86, p=0.005). Respondents who were
more likely to accept the seasonal vaccine were also more likely to accept the H1N1 vaccine
(χ2=95.7, p<.001). There was no significant difference in the number of participants who
were willing to pay for either the seasonal (χ2=2.62) or H1N1 vaccine (χ2=2.70) (t=-1.55,
p=.122).
Seasonal influenza vaccine acceptance
Fifteen percent (n=77) of respondents had been vaccinated for seasonal influenza within
three months prior to survey administration. The overall seasonal influenza vaccine
acceptance rate (i.e., those already vaccinated plus those who intended to get vaccinated)
was 39% (n=196). In multivariate analysis, acceptance of seasonal influenza vaccination
was associated with disagreement about H1N1 conspiracy beliefs (community perceptions
of H1N1) [OR=1.53, CI (1.16, 2.01)] and having had the flu shot in the past 5 years
[OR=3.53, CI (2.16, 5.78)]. Respondents with a general positive opinion about getting the
H1N1 vaccine were more likely to accept the seasonal influenza vaccination [OR=0.43, CI
(0.32, 0.59)]. Socially-perceived approval of flu shots (normative approval) [OR=1.12, CI
(0.77, 1.65), health insurance status [OR=0.53, CI (0.32, 0.90), and educational level were
not significantly associated with seasonal vaccine acceptance [OR=0.80, CI (0.62, 1.03).
H1N1 influenza vaccine acceptance
None of the respondents had been vaccinated against H1N1 at survey administration as the
vaccine was not widely available at that time. The acceptability rate for H1N1 influenza
vaccination was 38% (n=191). Acceptance was associated with favorable community
perceptions of H1N1 and disagreement with vaccine conspiracy beliefs [OR=2.15, CI (1.57,
2.95)] and having had the flu shot in the past 5 years [OR=2.50, CI (1.52, 4.10)].
Respondents who had a general negative opinion about the H1N1-related benefits were less
likely to accept vaccination [OR=0.23, CI (0.16, 0.33)].
Acceptance of the H1N1 influenza vaccine was associated with greater belief that the
decision to take a flu shot could be influenced by physicians [OR=1.94, CI (1.31, 2.86)].
Vaccine acceptors also were more likely than vaccine rejecters to believe health departments
would be an excellent place to get the vaccine [OR=2.71, CI (1.74, 4.21)]. Notably, eleven
percent (n=54) of refusing respondents also said they simply did not take vaccines of any
kind.
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Communication Messages and Dissemination Approaches
Attitudes toward communication approaches also varied by demographic characteristics.
Males were more likely to say friends (χ2=6.65, p=.01), employers (χ2=6.26, p=.01),
schools (χ2=6.57, p=.01), and Facebook (χ2=4.42, p=.04) would influence members of their
community to take a flu vaccine. Black/African Americans believed that churches (χ2=4.23,
p=.04) could effectively promote vaccine uptake and that grocery stores (χ2=7.93, p=.005)
would be another ideal place to obtain a flu vaccine. Those under 64 years of age were more
likely to go to a health department (F=5.26, p=0.01) to obtain a flu vaccine in the future
compared to those over 64 years of age. Those who previously received a seasonal influenza
vaccine in the past 5 years were more likely to think that churches (χ2=8.32, p=.004) and
grocery stores (χ2=5.18, p=.02) would be good places to obtain flu vaccines in the future. In
addition, they were more likely to look at Facebook ads (χ2=5.58, p=.02) related to flu
vaccine and Twitter posts (χ2=5.37, p=.02).
Discussion
Although participants were more likely to accept an H1N1 influenza vaccine than a seasonal
influenza vaccine, acceptance for both seasonal (31.4%) and H1N1 influenza (38.0%)
vaccines were low among our study population. This finding is consistent with other studies
that have found minority populations may be less likely to accept immunizations in general,
as well as influenza vaccination specifically [54-57]. This phenomenon may result from
negative vaccine attitudes in the community and poor experiences with healthcare providers
along with general concerns about vaccination safety and side effects [55, 56]. Simulation
studies have demonstrated that addressing vaccine “skeptics” in communities has critical
epidemiologic implications for decreasing vulnerability to vaccine-preventable disease [58,
59]. However, reaching and effectively communicating with lower-income minority
community members on vaccine issues can be challenging [60]. Health promotion studies
have identified interpersonal communication routes combined with the role of social
networks as interventional opportunities that can be harnessed [61]. Therefore, identifying
and mobilizing opinion leaders (“information mavens”) from marginalized communities
may be useful in this context as this approach has been effective with similar populations
[61, 62].
Targeting community opinion leaders with previous influenza vaccination history may be an
optimal strategy to increase vaccine uptake in the future [21]. Our findings demonstrate that
participants who would accept a seasonal influenza vaccine were also more likely to accept
an H1N1 influenza vaccine, indicating less mistrust of vaccines in general. Moreover, those
who had a flu shot in the past five years were most likely to obtain both seasonal and H1N1
immunizations in the future. This behavioral correlate has also been highlighted as a robust
factor in predicting H1N1 vaccine intention across diverse populations [63]. With an 11%
general vaccine refusal rate, we recognize that enormous opportunity exists to push a
substantial proportion of vaccine “fence sitters” who are unsure about immunization
necessity to adopters [64]. We therefore argue for the prioritization of effective messaging
about influenza vaccination to not only sustain the willingness of persons to annually obtain
flu shots but also to serve as effective health behavior models to others [65]. Such “tipping
point” efforts have enormous longer term potential for impacting social norms among those
who may not necessarily perceive themselves to be at risk for infection or in need of a flu
vaccine [65].
This study focused on salient government conspiracy and vaccine-related issues which are
important considerations in promoting vaccine acceptance among minority populations [66].
Participants that expressed a greater sense of trust in the U.S. government, as demonstrated
by their disagreement with conspiracy belief items on the “Community Perceptions” scale,
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were more likely to accept both vaccines. This factor has been positively associated with
influenza vaccine intention across cultural contexts [67]. Thus, it is critical for governmental
bodies to provide clear and timely information to citizens in pandemic situations as well as
during normal influenza epidemic cycles [66, 68, 69]. This is especially important for black/
African Americans whose government mistrust is still widespread as a result of the
Tuskegee experiment and similar events [70].
Some hypothesized factors thought to be associated with vaccine acceptance did not
materialize in our study. Social norms, a well-studied predictor of behavior posited by the
Theory of Reasoned Action, Theory of Planned Behavior, and Integrated Behavioral Model
[71], was not influential of vaccine intention in this study. This was of interest to us as mean
values on items measuring approval of taking a flu shot resulted in moderate agreement with
a correspondingly strong scale alpha level (0.90). We therefore interpret the finding to mean
that referent opinion is subsumed in our attitudinal measure, also significantly associated
with obtaining both types of immunizations. In that scale we explore whether taking a flu
shot will set an example to the community, that obtaining the immunization would protect
the health of a family, and if taking it would encourage others to do the same. Cross-cultural
influenza vaccination studies have demonstrated the independent effect of normative
appraisal in shaping vaccine intention [72]. However, this effect is realized in contexts
where social norms have been shaped that favor influenza vaccination [72]. With overall
lower levels of community acceptance of influenza vaccination, we assert that positive
normative consideration operates differently as a component of attitude formation to
reconcile negative cultural norms around vaccines.
Disease salience, or the consideration of influenza as an equal or greater threat to the
community compared to other health concerns, also did not impact H1N1 acceptance.
Perceived threat of disease, originally discussed in the Health Belief Model as a combination
of perceived susceptibility and perceived severity of disease [35], is a well-known correlate
of acceptance for a plethora of vaccines [72-75]. Our inventory of comparative health
concerns included leading causes of morbidity and mortality among black/African
Americans such as breast cancer, HIV/AIDS, depression, and substance abuse.
Consideration of these health problems did not result in greater H1N1 threat appraisal. In
other words, our participants were neutral in their view of their own H1N1 susceptibility and
its severity. As a consequence this did not impact their vaccine decision-making in contrast
to other studies that have examined threat appraisal [21].
Two sociodemographic factors, higher educational attainment and personal health insurance
coverage, were not associated with acceptance of either vaccine. Previous research has
demonstrated a link between influenza vaccination coverage and insurance status [76].
However this link is more tenuous among minorities from lower income communities who
have insurance as vaccine coverage rates remain suboptimal [76]. It has been posited that
issues such as lack of transportation may preclude those who have insurance from receiving
care including preventive health services. Additionally, educational attainment was not
associated with vaccine acceptance. This finding again suggests that affective concerns such
as cultural norms and beliefs may trump knowledge in vaccine appraisal. Thus, exploration
of the role of health literacy may be warranted [77]. Finally, we found no difference with
respect to cost considerations to obtain seasonal or H1N1 vaccine. This indicates that
payment and subsidies for influenza vaccination, particularly for those groups recommended
by Advisory Committee on Immunization Practices (ACIP), need to be maintained in the
future to achieve increased population coverage [78].
Communication analyses by groups revealed differences by race/ethnicity, age, gender, and
previous vaccination behavior on promotional strategies that may be effective in increasing
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future influenza vaccine acceptance. Most of our population (≤63 years of age) pointed to
health departments as places to obtain future influenza immunizations. This finding relates
to cost considerations among this population for whom vaccinations are offered for free or a
significantly reduced cost at these locations for pediatric and adult clients. Men also
identified institutional entities such as schools and employers as critical partners in
promoting influenza vaccination in their communities. Thus, future policies may focus on
facilitating employer- and school-based immunization delivery in these locations. Men also
indicated that friends are important sources of influenza vaccine information [61, 62]. This
finding suggests the importance of identifying men in communities who can serve as
immunization role models and who can effectively mobilize their friends to alter negative
social norms around vaccination [61, 62].
Black/African Americans and those who had obtained flu shots in the past five years also
cited grocery stores as places to obtain vaccines in the future. With the rise of retail clinics
that are often situated within grocery stores and pharmacies in urban community settings,
these venues are now viewed as acceptable alternatives to emergency departments and
urgent care centers [79, 80]. Indeed, previous studies have shown that retail clinics are
effectively delivering immunization services at a reduced cost compared to private offices,
clinics, and hospitals. Moreover, many of these locales accept Medicaid thereby ensuring
that lower income persons in urban areas are able to obtain flu shots in these convenient
places [81, 82].
It is important to highlight the important role faith institutions have as a potential
intervention point in future immunization campaigns. Consistent with other studies that have
found churches are critical partners in health message dissemination on novel vaccines given
their trusted status in the community [83], black/African Americans and those who received
flu shots in the past five years also indicated their potential as an ally in driving flu shot
campaigns. Finally, the influence of social media is underscored in our findings. Facebook
and Twitter are viewed as important sources of health information for those who have
previously received flu shots (vaccine “acceptors”) and men.
Overall we found that physician recommendation of vaccination and promotion of
immunization by health departments are associated with vaccine acceptance. This is
consistent with other studies that have examined the role of providers and clinics to increase
vaccine coverage in minority communities [84]. It has been suggested that public health
practitioners can do a better job to incorporate social media into health campaigns,
especially with involvement of providers and health departments in message delivery [85,
86]. As social media are widely accessible on a number of platforms including smartphones
and cellular devices that are carried by community members, diffusion of credible public
health information in this culturally-congruent manner holds great promise for reaching this
audience [87, 88]. With trusted community physicians as message deliverers using
Facebook, Twitter, and other social media such as YouTube, cultural norms related to
vaccine refusal could be more effectively addressed in a new “informal learning
environment” [88, 89]. An integrated marketing communication campaign strategy for
influenza vaccination therefore would greatly benefit from the ironic “social contagion”
power of viral messaging [90, 91].
Limitations
This study had several limitations including its serial cross-sectional design. Cross-sectional
studies limit the conclusions that can be made regarding temporality, but this is not as
important as determining the interplay of perceptions of feelings about vaccine acceptability
at the time of the outbreak. Second, our primary outcome was vaccine acceptance, rather
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than documented receipt of vaccination. It is likely that not everyone who reported vaccine
acceptance would actually get vaccinated [20-21, 28-29]. Social desirability bias may also
have increased the degree of vaccine acceptance as participants may have indicated that they
would accept a vaccine in order to potentially please the interviewer. In the future,
computer-assisted questionnaires may be utilized to avoid this phenomenon. In addition,
there is potential for systematic and selection bias in the venue-based recruitment. Finally,
the sample comprised a small, predominantly minority group of adults in a Southeastern
city. Thus, the results may not be generalizable to other populations.
Conclusions
This study is one of the first to examine racial and ethnic minorities’ acceptance of both
seasonal and H1N1 vaccination. Overall, vaccine acceptance was low in this population.
Factors associated with acceptance of both influenza vaccines indicate that immunization
attitudes, disagreement with conspiracy beliefs, and past obtainment of flu shots are
associated with vaccine acceptance. Future interventions geared towards enhancing seasonal
and pandemic influenza vaccinations may benefit from emphasizing the benefits of vaccine
protection to self and others, reducing mistrust of health messages from the government, and
capitalizing on “culture-centered” communication approaches that include accessible,
trusted institutions and social networks in “viral” campaigns.
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• We examined H1N1 and seasonal vaccine acceptance among minorities.
• We report low H1N1 and seasonal vaccine acceptance in this population.
• Three key factors are associated with vaccine acceptance.
• Providers have an instrumental role in promoting vaccine acceptance via social
media.
• Churches, grocery stores, and health departments are important intervention
sites.
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18 – 24 111 22.1
25 – 63 354 70.4
64 – 70 12 2.4
Educational Attainment (missing=24) 4.8
K-8 grade 9 1.8
9-11 grade 75 14.9
HS graduate/GED 214 42.5
Tech/Voc/Associate’s degree 105 20.9
Bachelor’s degree 58 11.5
Master’s degree 13 2.6
Doctorate 5 1.0
Racial/Ethnic Background (missing=27) 5.4
Hispanic/Latino/Chicano 31 6.2
Non-Hispanic: African American/Black 399 79.3
Non-Hispanic: Multiracial/Multicultural 28 5.6
Asian/Asian American/Pacific Islander 12 2.4
Native American/American Indian/Alaskan 6 1.2
Employment Status (missing=5) 1.0
Employed (full time) 117 23.3
Employed (part time) 94 18.7
Unemployed 245 48.7
Other 42 8.3
Annual Household Income (missing=16) 3.2
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Table 3
Factors Associated with Influenza Vaccine Acceptability
Influential Factors Model 1 – OddsRatio (95% CI)
Model 2 – Odds
Ratio (95% CI)
H1N1
Immunization Attitudes 0.29 (0.18, 0.48) 0.23 (0.16, 0.33)
Community Perceptions of H1N1 1.63 (1.13, 2.35) 2.15 (1.57, 2.95)
Had flu shot in past 5 years 2.67 (1.57, 4.55) 2.50 (1.52, 4.10)
Normative Flu Shot Approval 0.70 (0.46, 1.05)
Disease Salience 1.62 (1.06, 2.47)
Education 1.05 (0.81, 1.36)
Income 0.82 (0.59, 1.14)
Seasonal
Immunization Attitudes 0.40 (0.26, 0.64) 0.43 (0.32, 0.59)
Community Perceptions of H1N1 1.64 (1.23, 2.19) 1.53 (1.16, 2.01)
Had flu shot in past 5 years 3.24 (1.92, 5.48) 3.53 (2.16, 5.78)
Normative Flu Shot Approval 1.12 (0.77, 1.65)
Education 0.80 (0.62, 1.03)
Health Insurance 0.53 (0.32, 0.90)
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